Literature DB >> 25269723

[Endocrine tumors: clinical overview].

G Leidig-Bruckner1.   

Abstract

The term endocrine tumor incorporates all neoplasms which originate from the various endocrine organs. Endocrine tumors can be characterized by different criteria: localization, endocrine function, dignity (i.e. tumorigenesis, sporadic or hereditary). These characteristics also determine the clinical outcome. The clinical history, symptoms and physical examination findings (e.g. amenorrhea, skin alterations, striae, virilization, increased blood pressure and flush) direct the diagnostic process of functioning endocrine tumors. Laboratory findings (endocrine parameters) are needed to establish a diagnosis supplemented by imaging for localization and special investigations (ophthalmological examination). In hereditary tumor syndromes, the familial history and molecular genetic testing and screening of family members are essential for establishing the diagnosis and achieve optimal and early treatment. Ideally, affected family members can be treated before clinical symptoms or metastatic disease occurs, improving outcome and prognosis. Incidentalomas are increasingly found due to widespread use of imaging techniques, especially in the thyroid, adrenal glands, pancreas and pituitary gland. In incidentalomas the functional status and risk of malignancy has to be evaluated as both parameters determine therapy decisions. The aim of this introductory article is to give an overview about particular features of endocrine tumors, clinical and related aspects for the diagnostic and therapeutic approach. The clinical features of tumors of the pituitary, parathyroid and adrenal glands and the gastroenteropancreatic system are summarized according to localization.

Entities:  

Mesh:

Year:  2014        PMID: 25269723     DOI: 10.1007/s00117-014-2687-6

Source DB:  PubMed          Journal:  Radiologe        ISSN: 0033-832X            Impact factor:   0.635


  12 in total

Review 1.  Childhood craniopharyngioma--current concepts in diagnosis, therapy and follow-up.

Authors:  Hermann L Müller
Journal:  Nat Rev Endocrinol       Date:  2010-09-28       Impact factor: 43.330

Review 2.  Phaeochromocytoma.

Authors:  Jacques W M Lenders; Graeme Eisenhofer; Massimo Mannelli; Karel Pacak
Journal:  Lancet       Date:  2005 Aug 20-26       Impact factor: 79.321

3.  [Adrenal tumors: principles of imaging and differential diagnostics].

Authors:  C Degenhart
Journal:  Radiologe       Date:  2014-10       Impact factor: 0.635

Review 4.  Multiple endocrine neoplasia type 2. Clinical features and screening.

Authors:  F Raue; K Frank-Raue; A Grauer
Journal:  Endocrinol Metab Clin North Am       Date:  1994-03       Impact factor: 4.741

Review 5.  Nuclear medicine in the detection, staging and treatment of gastrointestinal carcinoid tumours.

Authors:  Kjell Oberg; Barbro Eriksson
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2005-06       Impact factor: 4.690

6.  [Radiologic and nuclear medicine diagnosis and therapy of thyroid disorders: Part II: Malignant thyroid diseases].

Authors:  C M Zechmann; S Haufe
Journal:  Radiologe       Date:  2012-08       Impact factor: 0.635

Review 7.  Adrenal incidentaloma.

Authors:  L M Brunt; J F Moley
Journal:  World J Surg       Date:  2001-07       Impact factor: 3.352

Review 8.  Clinical review 110: Diagnosis and treatment of pituitary tumors.

Authors:  P U Freda; S L Wardlaw
Journal:  J Clin Endocrinol Metab       Date:  1999-11       Impact factor: 5.958

9.  Incidental detection of pancreatic neuroendocrine tumors: an analysis of incidence and outcomes.

Authors:  Asima Cheema; Jill Weber; Jonathan R Strosberg
Journal:  Ann Surg Oncol       Date:  2012-02-14       Impact factor: 5.344

Review 10.  The gastroenteropancreatic neuroendocrine cell system and its tumors: the WHO classification.

Authors:  Günter Klöppel; Aurel Perren; Philipp U Heitz
Journal:  Ann N Y Acad Sci       Date:  2004-04       Impact factor: 5.691

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.